Everolimus (Certican)

DRUG2 trials

Sponsors

Novartis Pharmaceuticals, Novartis

Conditions

Heart TransplantationOrgan Transplantation, Renal Transplantation

Phase 3

A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients

CompletedNCT00098007

Novartis PharmaceuticalsHeart Transplantation

Start: 2004-08-09End: 2007-01-08Updated: 2017-02-23

Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients

CompletedNCT00154284

NovartisOrgan Transplantation, Renal Transplantation

Start: 2005-07-31End: 2008-07-31Updated: 2018-08-09